Mutation of Epigenetic Regulators at Diagnosis Is an Independent Predictor of Tyrosine Kinase Inhibitor Treatment Failure in Chronic Myeloid Leukemia: A Report From the RESIDIAG Study.

Authors :: Guerineau H
Cayuela JM
Dulucq S
Tran Quang V
Tarfi S
Gricourt G
Barathon Q
Joy C
Wagner-Ballon O
Morisset S
Nicolini FE
Brunet E
Maury S
Roy L
Etienne G
Réa D
Sloma I
Source :: American journal of hematology [Am J Hematol] 2024 Dec 10. Date of Electronic Publication: 2024 Dec 10.
Publication Year :: 2024
Publisher :: Ahead of Print

Full Text Access

Tools